Literature DB >> 19820907

Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism.

Andreas N Schüring1, Friederike Lutz, Frank Tüttelmann, Jörg Gromoll, Ludwig Kiesel, Martin Götte.   

Abstract

The heparan sulfate proteoglycan syndecan-3 (SDC3) is a novel regulator of feeding behavior and body weight. Recently, an association of SDC3 polymorphisms with obesity has been observed in Koreans. As female obesity is associated with hyperandrogenism and infertility, we studied the role of SDC3 polymorphisms in female individuals undergoing diagnostics prior to infertility treatment. For this purpose, endocrine parameters and body mass index of 249 women were assessed. Genotyping of V208I, D303N, and T329I was performed with TaqMan technology using lymphocyte-derived DNA and allelic discrimination polymerase chain reaction. Chi-square test, Student's t test, and one-way analysis of variance were used for statistical analysis. We find that an infrequent genotype and allele variation of T329I correlated with obesity (p = 0.028). Genotype and alleles of V208I were associated with luteinizing hormone (p = 0.007 and p = 0.001, respectively), luteinizing hormone/follicle-stimulating hormone (p = 0.002 and p < 0.005, respectively), 17 hydroxyprogesterone (p = 0.007 and p = 0.001, respectively), androstenedione (p = 0.046 and p = 0.013, respectively), and sex hormone-binding globulin (p = 0.021). We conclude that marked ethnic differences of the SDC3 SNP distribution in our European population could account for correlations less predominant compared to Koreans. While infrequent variations of T329I correlated with obesity, V208I was associated with endocrine parameters related to hyperandrogenism. These findings indicate that SDC3 polymorphisms could contribute to the link between female hyperandrogenism and obesity and suggest a novel potential role for SDC3 as a modulator of gonadal steroid function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820907     DOI: 10.1007/s00109-009-0529-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  31 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Clinical utility of sex hormone-binding globulin measurement.

Authors:  M Pugeat; J C Crave; J Tourniaire; M G Forest
Journal:  Horm Res       Date:  1996

Review 3.  Androgen production in women.

Authors:  Henry G Burger
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

4.  Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.

Authors:  Andrea D Coviello; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

Review 5.  Heritability and the risk of developing androgen excess.

Authors:  M Kashar-Miller; R Azziz
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

6.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Obesity-associated lymphoedematous mucinosis.

Authors:  Franco Rongioletti; Pietro Donati; Ada Amantea; Gerardo Ferrara; Martina Montinari; Francesca Santoro; Aurora Parodi
Journal:  J Cutan Pathol       Date:  2009-02-10       Impact factor: 1.587

Review 8.  The role of syndecans in the regulation of body weight and synaptic plasticity.

Authors:  Ofer Reizes; Stephen C Benoit; Deborah J Clegg
Journal:  Int J Biochem Cell Biol       Date:  2007-06-30       Impact factor: 5.085

9.  Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.

Authors:  E June Davies; Fiona H Blackhall; Jonathan H Shanks; Guido David; Alan T McGown; Ric Swindell; Richard J Slade; Pierre Martin-Hirsch; John T Gallagher; Gordon C Jayson
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

10.  Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.

Authors:  Larissa C Wilsie; Amanda M Gonzales; Robert A Orlando
Journal:  Lipids Health Dis       Date:  2006-08-31       Impact factor: 3.876

View more
  4 in total

1.  Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.

Authors:  Rachel K Okolicsanyi; Anne Buffiere; Jose M E Jacinto; Diego Chacon-Cortes; Suzanne K Chambers; Philippa H Youl; Larisa M Haupt; Lyn R Griffiths
Journal:  Tumour Biol       Date:  2014-11-01

2.  Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice.

Authors:  Kelly L Sams; Chinatsu Mukai; Brooke A Marks; Chitvan Mittal; Elena Alina Demeter; Sophie Nelissen; Jennifer K Grenier; Ann E Tate; Faraz Ahmed; Scott A Coonrod
Journal:  Reprod Biol Endocrinol       Date:  2022-10-12       Impact factor: 4.982

3.  Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.

Authors:  Anett Hudák; Annamária Letoha; László Szilák; Tamás Letoha
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

4.  Study of seven single-nucleotide polymorphisms identified in East Asians for association with obesity in a Taiwanese population.

Authors:  Wei-Hsin Huang; Lee-Ching Hwang; Hsin-Lung Chan; Hsiang-Yu Lin; Yung-Hsiang Lin
Journal:  BMJ Open       Date:  2016-08-10       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.